{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:37:36Z","timestamp":1783035456597,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"crossref","award":["PP-1606-08778"],"award-info":[{"award-number":["PP-1606-08778"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Augusta University Culver Vision Discovery Institute","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY028569"],"award-info":[{"award-number":["R01EY028569"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12035-019-01691-w","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T18:10:27Z","timestamp":1562436627000},"page":"8589-8602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis"],"prefix":"10.1007","volume":"56","author":[{"given":"Chithra D.","family":"Palani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman Y.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailedra","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth B.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-879X","authenticated-orcid":false,"given":"S. Priya","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,6]]},"reference":[{"key":"1691_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awu335","volume":"138","author":"LJ Balcer","year":"2015","unstructured":"Balcer LJ, Miller DH, Reingold SC, Cohen JA (2015) Vision and vision-related outcome measures in multiple sclerosis. Brain. 138:11\u201327","journal-title":"Brain."},{"key":"1691_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","volume":"31","author":"RE Sakai","year":"2011","unstructured":"Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31:362\u2013373","journal-title":"J Neuroophthalmol"},{"key":"1691_CR3","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/NXI.0000000000000135","volume":"2","author":"SL Galetta","year":"2015","unstructured":"Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E, Cadavid D, Balcer LJ (2015) Acute optic neuritis: unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinflamm 2:e135","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1691_CR4","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1167\/iovs.10-5676","volume":"52","author":"T Sakai","year":"2011","unstructured":"Sakai T, Ishihara T, Higaki M, Akiyama G, Tsuneoka H (2011) Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 52:1516\u20131521","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1691_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","volume":"119","author":"SD Walter","year":"2012","unstructured":"Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG et al (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 119:1250\u20131257","journal-title":"Ophthalmology."},{"key":"1691_CR6","doi-asserted-by":"publisher","first-page":"e50947","DOI":"10.1371\/journal.pone.0050947","volume":"7","author":"LA Abel","year":"2012","unstructured":"Abel LA, Bowman EA, Velakoulis D, Fahey MC, Desmond P, Macfarlane MD, Looi JCL, Adamson CL et al (2012) Saccadic eye movement characteristics in adult niemann-pick type c disease: relationships with disease severity and brain structural measures. PLoS One 7:e50947","journal-title":"PLoS One"},{"key":"1691_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1212\/WNL.43.4.662","volume":"43","author":"DW Paty","year":"1993","unstructured":"Paty DW, Li DK (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Ii. Mri analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Ubc ms\/mri study group and the ifnb multiple sclerosis study group. Neurology. 43:662\u2013667","journal-title":"Neurology."},{"key":"1691_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899\u2013910","journal-title":"N Engl J Med"},{"key":"1691_CR9","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1080\/14656566.2017.1373093","volume":"18","author":"K Thomas","year":"2017","unstructured":"Thomas K, Proschmann U, Ziemssen T (2017) Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis. Expert Opin Pharmacother 18:1649\u20131660","journal-title":"Expert Opin Pharmacother"},{"key":"1691_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2146\/ajhp140023","volume":"72","author":"RH Thomas","year":"2015","unstructured":"Thomas RH, Wakefield RA (2015) Oral disease-modifying therapies for relapsing-remitting multiple sclerosis. Am J Health Syst Pharm 72:25\u201338","journal-title":"Am J Health Syst Pharm"},{"key":"1691_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (eae) model of ms: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189","journal-title":"Handb Clin Neurol"},{"key":"1691_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (eae) as a model for multiple sclerosis (ms). Br J Pharmacol 164:1079\u20131106","journal-title":"Br J Pharmacol"},{"key":"1691_CR13","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","volume":"182","author":"N Nath","year":"2009","unstructured":"Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S (2009) Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 182:8005\u20138014","journal-title":"J Immunol"},{"key":"1691_CR14","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/mt.2013.104","volume":"21","author":"V Talla","year":"2013","unstructured":"Talla V, Yu H, Chou TH, Porciatti V, Chiodo V, Boye SL, Hauswirth WW, Lewin AS et al (2013) Nadh-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the eae animal model of ms. Mol Ther 21:1876\u20131888","journal-title":"Mol Ther"},{"key":"1691_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1742-2094-9-213","volume":"9","author":"R Brambilla","year":"2012","unstructured":"Brambilla R, Dvoriantchikova G, Barakat D, Ivanov D, Bethea JR, Shestopalov VI (2012) Transgenic inhibition of astroglial nf-kappab protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J Neuroinflammation 9:213","journal-title":"J Neuroinflammation"},{"key":"1691_CR16","doi-asserted-by":"crossref","unstructured":"Dal Monte M, Cammalleri M, Locri F, Amato R, Marsili S, Rusciano D, Bagnoli P (2018) Fatty acids dietary supplements exert anti-inflammatory action and limit ganglion cell degeneration in the retina of the eae mouse model of multiple sclerosis. Nutrients. 10","DOI":"10.3390\/nu10030325"},{"key":"1691_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.msard.2018.11.010","volume":"27","author":"C Nishioka","year":"2019","unstructured":"Nishioka C, Liang HF, Barsamian B, Sun SW (2019) Sequential phases of rgc axonal and somatic injury in eae mice examined using dti and oct. Mult Scler Relat Disord 27:315\u2013323","journal-title":"Mult Scler Relat Disord"},{"key":"1691_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12974-018-1208-3","volume":"15","author":"AT Wilmes","year":"2018","unstructured":"Wilmes AT, Reinehr S, Kuhn S, Pedreiturria X, Petrikowski L, Faissner S et al (2018) Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model. J Neuroinflammation 15:183","journal-title":"J Neuroinflammation"},{"key":"1691_CR19","first-page":"1503","volume":"22","author":"CM Larabee","year":"2016","unstructured":"Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC et al (2016) Loss of nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis 22:1503\u20131513","journal-title":"Mol Vis"},{"key":"1691_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB (2018) Arginase: a multifaceted enzyme important in health and disease. Physiol Rev 98:641\u2013665","journal-title":"Physiol Rev"},{"key":"1691_CR21","doi-asserted-by":"publisher","first-page":"e22460","DOI":"10.1371\/journal.pone.0022460","volume":"6","author":"SP Narayanan","year":"2011","unstructured":"Narayanan SP, Suwanpradid J, Saul A, Xu Z, Still A, Caldwell RW, Caldwell RB (2011) Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity. PLoS One 6:e22460","journal-title":"PLoS One"},{"key":"1691_CR22","doi-asserted-by":"publisher","first-page":"e2483","DOI":"10.1038\/cddis.2016.295","volume":"7","author":"E Shosha","year":"2016","unstructured":"Shosha E, Xu Z, Yokota H, Saul A, Rojas M, Caldwell RW, Caldwell RB, Narayanan SP (2016) Arginase 2 promotes neurovascular degeneration during ischemia\/reperfusion injury. Cell Death Dis 7:e2483","journal-title":"Cell Death Dis"},{"key":"1691_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3389\/fnins.2018.00970","volume":"12","author":"Z Xu","year":"2018","unstructured":"Xu Z, Fouda AY, Lemtalsi T, Shosha E, Rojas M, Liu F et al (2018) Retinal neuroprotection from optic nerve trauma by deletion of arginase 2. Front Neurosci 12:970","journal-title":"Front Neurosci"},{"key":"1691_CR24","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M115.679068","volume":"290","author":"LM Poisson","year":"2015","unstructured":"Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A et al (2015) Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J Biol Chem 290:30697\u201330712","journal-title":"J Biol Chem"},{"key":"1691_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41419-018-1051-6","volume":"9","author":"AY Fouda","year":"2018","unstructured":"Fouda AY, Xu Z, Shosha E, Lemtalsi T, Chen J, Toque HA, Tritz R, Cui X et al (2018) Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses. Cell Death Dis 9:1001","journal-title":"Cell Death Dis"},{"key":"1691_CR26","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez AR, de Sevilla Muller LP, Brecha NC (2014) The rna binding protein rbpms is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol 522:1411\u20131443","journal-title":"J Comp Neurol"},{"key":"1691_CR27","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicolas","year":"2009","unstructured":"Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, Salinas-Navarro M et al (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50:3860\u20133868","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1691_CR28","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.biopha.2017.11.066","volume":"96","author":"Q Liu","year":"2017","unstructured":"Liu Q, Li H, Yang J, Niu X, Zhao C, Zhao L, Wang Z (2017) Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis. Biomed Pharmacother 96:1363\u20131370","journal-title":"Biomed Pharmacother"},{"key":"1691_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jnc.13770","volume":"139","author":"AW Smith","year":"2016","unstructured":"Smith AW, Rohrer B, Wheless L, Samantaray S, Ray SK, Inoue J, Azuma M, Banik NL (2016) Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. J Neurochem 139:270\u2013284","journal-title":"J Neurochem"},{"key":"1691_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2016.12.057","volume":"639","author":"Y Azuchi","year":"2017","unstructured":"Azuchi Y, Kimura A, Guo X, Akiyama G, Noro T, Harada C, Nishigaki A, Namekata K et al (2017) Valproic acid and ask1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis. Neurosci Lett 639:82\u201387","journal-title":"Neurosci Lett"},{"key":"1691_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/jnen\/nlw114","volume":"76","author":"V Gudi","year":"2017","unstructured":"Gudi V, Gai L, Herder V, Tejedor LS, Kipp M, Amor S, S\u00fchs KW, Hansmann F et al (2017) Synaptophysin is a reliable marker for axonal damage. J Neuropathol Exp Neurol 76:109\u2013125","journal-title":"J Neuropathol Exp Neurol"},{"key":"1691_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1742-2094-10-120","volume":"10","author":"L Horstmann","year":"2013","unstructured":"Horstmann L, Schmid H, Heinen AP, Kurschus FC, Dick HB, Joachim SC (2013) Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J Neuroinflammation 10:120","journal-title":"J Neuroinflammation"},{"key":"1691_CR33","doi-asserted-by":"crossref","unstructured":"Niwa M, Aoki H, Hirata A, Tomita H, Green PG, Hara A (2016) Retinal cell degeneration in animal models. Int J Mol Sci 17","DOI":"10.3390\/ijms17010110"},{"key":"1691_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/imm.12926","volume":"155","author":"M Choudry","year":"2018","unstructured":"Choudry M, Tang X, Santorian T, Wasnik S, Xiao J, Xing W, Lau KHW, Mohan S et al (2018) Deficient arginase ii expression without alteration in arginase i expression attenuated experimental autoimmune encephalomyelitis in mice. Immunology. 155:85\u201398","journal-title":"Immunology."},{"key":"1691_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2006.05.019","volume":"178","author":"Y Guan","year":"2006","unstructured":"Guan Y, Shindler KS, Tabuena P, Rostami AM (2006) Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in mog-specific tcr transgenic mice. J Neuroimmunol 178:40\u201348","journal-title":"J Neuroimmunol"},{"key":"1691_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fneur.2011.00050","volume":"2","author":"TA Quinn","year":"2011","unstructured":"Quinn TA, Dutt M, Shindler KS (2011) Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol 2:50","journal-title":"Front Neurol"},{"key":"1691_CR37","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/cddis.2014.23","volume":"5","author":"SP Narayanan","year":"2014","unstructured":"Narayanan SP, Xu Z, Putluri N, Sreekumar A, Lemtalsi T, Caldwell RW, Caldwell RB (2014) Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis 5:e1075","journal-title":"Cell Death Dis"},{"key":"1691_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-006-8787-y","volume":"26","author":"G Muthian","year":"2006","unstructured":"Muthian G, Raikwar HP, Johnson C, Rajasingh J, Kalgutkar A, Marnett LJ, Bright JJ (2006) Cox-2 inhibitors modulate il-12 signaling through jak-stat pathway leading to th1 response in experimental allergic encephalomyelitis. J Clin Immunol 26:73\u201385","journal-title":"J Clin Immunol"},{"key":"1691_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2005.01.020","volume":"162","author":"AC dos Santos","year":"2005","unstructured":"dos Santos AC, Barsante MM, Arantes RM, Bernard CC, Teixeira MM, Carvalho-Tavares J (2005) Ccl2 and ccl5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis\u2014an intravital microscopy study. J Neuroimmunol 162:122\u2013129","journal-title":"J Neuroimmunol"},{"key":"1691_CR40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20060285","volume":"203","author":"C Sutton","year":"2006","unstructured":"Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC (2006) A crucial role for interleukin (il)-1 in the induction of il-17-producing t cells that mediate autoimmune encephalomyelitis. J Exp Med 203:1685\u20131691","journal-title":"J Exp Med"},{"key":"1691_CR41","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/eji.201545800","volume":"45","author":"HM Grifka-Walk","year":"2015","unstructured":"Grifka-Walk HM, Giles DA, Segal BM (2015) Il-12-polarized th1 cells produce gm-csf and induce eae independent of il-23. Eur J Immunol 45:2780\u20132786","journal-title":"Eur J Immunol"},{"key":"1691_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bpa.12477","volume":"27","author":"W Barclay","year":"2017","unstructured":"Barclay W, Shinohara ML (2017) Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (eae). Brain Pathol 27:213\u2013219","journal-title":"Brain Pathol"},{"key":"1691_CR43","doi-asserted-by":"publisher","first-page":"E6065","DOI":"10.1073\/pnas.1722041115","volume":"115","author":"BA McKenzie","year":"2018","unstructured":"McKenzie BA, Mamik MK, Saito LB, Boghozian R, Monaco MC, Major EO et al (2018) Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A 115:E6065\u2013E6074","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1691_CR44","doi-asserted-by":"crossref","first-page":"2954721","DOI":"10.1155\/2016\/2954721","volume":"2016","author":"R de Hoz","year":"2016","unstructured":"de Hoz R, Rojas B, Ramirez AI, Salazar JJ, Gallego BI, Trivino A et al (2016) Retinal macroglial responses in health and disease. Biomed Res Int 2016:2954721","journal-title":"Biomed Res Int"},{"key":"1691_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2015.11.059","volume":"469","author":"J Bao","year":"2016","unstructured":"Bao J, Zhu J, Luo S, Cheng Y, Zhou S (2016) Cxcr7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis. Biochem Biophys Res Commun 469:1\u20137","journal-title":"Biochem Biophys Res Commun"},{"key":"1691_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3389\/fphar.2017.00789","volume":"8","author":"L Lu","year":"2017","unstructured":"Lu L, Zhang X, Tong H, Zhang W, Xu P, Qu S (2017) Central administration of 5z-7-oxozeaenol protects experimental autoimmune encephalomyelitis mice by inhibiting microglia activation. Front Pharmacol 8:789","journal-title":"Front Pharmacol"},{"key":"1691_CR47","doi-asserted-by":"crossref","unstructured":"Birkner K, Wasser B, Loos J, Plotnikov A, Seger R, Zipp F, Witsch E, Bittner S (2017) The role of erk signaling in experimental autoimmune encephalomyelitis. Int J Mol Sci 18","DOI":"10.3390\/ijms18091990"},{"key":"1691_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/187152708784936699","volume":"7","author":"A Das","year":"2008","unstructured":"Das A, Guyton MK, Butler JT, Ray SK, Banik NL (2008) Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. CNS Neurol Disord Targets 7:313\u2013320","journal-title":"CNS Neurol Disord Targets"},{"key":"1691_CR49","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"J Zha","year":"1996","unstructured":"Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist bad in response to survival factor results in binding to 14-3-3 not bcl-x(l). Cell. 87:619\u2013628","journal-title":"Cell."},{"key":"1691_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.278.5338.687","volume":"278","author":"L del Peso","year":"1997","unstructured":"del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of bad through the protein kinase akt. Science. 278:687\u2013689","journal-title":"Science."},{"key":"1691_CR51","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","volume":"286","author":"A Bonni","year":"1999","unstructured":"Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the ras-mapk signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1358\u20131362","journal-title":"Science."},{"key":"1691_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","volume":"14","author":"M Hobom","year":"2004","unstructured":"Hobom M, Storch MK, Weissert R, Maier K, Radhakrishnan A, Kramer B, B\u00e4hr M, Diem R (2004) Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol (Zurich, Switzerland) 14:148\u2013157","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"Suppl 2","key":"1691_CR53","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","volume":"11","author":"MB Sattler","year":"2004","unstructured":"Sattler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, Bahr M et al (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11(Suppl 2):S181\u2013S192","journal-title":"Cell Death Differ"},{"key":"1691_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2567.2003.01713.x","volume":"110","author":"L Xu","year":"2003","unstructured":"Xu L, Hilliard B, Carmody RJ, Tsabary G, Shin H, Christianson DW, Chen YH (2003) Arginase and autoimmune inflammation in the central nervous system. Immunology. 110:141\u2013148","journal-title":"Immunology."},{"key":"1691_CR55","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1167\/iovs.05-0921","volume":"47","author":"CJ Lieven","year":"2006","unstructured":"Lieven CJ, Hoegger MJ, Schlieve CR, Levin LA (2006) Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest Ophthalmol Vis Sci 47:1477\u20131485","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1691_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuroscience.2011.04.041","volume":"185","author":"A Castegna","year":"2011","unstructured":"Castegna A, Palmieri L, Spera I, Porcelli V, Palmieri F, Fabis-Pedrini MJ, Kean RB, Barkhouse DA et al (2011) Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis. Neuroscience. 185:97\u2013105","journal-title":"Neuroscience."},{"key":"1691_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","volume":"65","author":"P Giannetti","year":"2014","unstructured":"Giannetti P, Politis M, Su P, Turkheimer F, Malik O, Keihaninejad S, Wu K, Reynolds R et al (2014) Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)c](r)-pk11195-pet pilot study. Neurobiol Dis 65:203\u2013210","journal-title":"Neurobiol Dis"},{"key":"1691_CR58","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1073\/pnas.1300313110","volume":"110","author":"WF Wu","year":"2013","unstructured":"Wu WF, Tan XJ, Dai YB, Krishnan V, Warner M, Gustafsson JA (2013) Targeting estrogen receptor beta in microglia and t cells to treat experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 110:3543\u20133548","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1691_CR59","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/NEN.0b013e3181f3a5b1","volume":"69","author":"OW Howell","year":"2010","unstructured":"Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R (2010) Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 69:1017\u20131033","journal-title":"J Neuropathol Exp Neurol"},{"key":"1691_CR60","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2004.11.004","volume":"160","author":"DK Dalton","year":"2005","unstructured":"Dalton DK, Wittmer S (2005) Nitric-oxide-dependent and independent mechanisms of protection from cns inflammation during th1-mediated autoimmunity: evidence from eae in inos ko mice. J Neuroimmunol 160:110\u2013121","journal-title":"J Neuroimmunol"},{"key":"1691_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000107286","volume":"14","author":"AS Farias","year":"2007","unstructured":"Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro dos Reis JR, Silva JS et al (2007) Nitric oxide and tnfalpha effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation. 14:32\u201338","journal-title":"Neuroimmunomodulation."},{"key":"1691_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2006.03.015","volume":"176","author":"MA Staykova","year":"2006","unstructured":"Staykova MA, Fordham SA, Bartell GJ, Cowden WB, Willenborg DO (2006) Nitric oxide contributes to the resistance of young sjl\/j mice to experimental autoimmune encephalomyelitis. J Neuroimmunol 176:1\u20138","journal-title":"J Neuroimmunol"},{"key":"1691_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2012.03.015","volume":"318","author":"S Ljubisavljevic","year":"2012","unstructured":"Ljubisavljevic S, Stojanovic I, Pavlovic R, Sokolovic D, Pavlovic D, Cvetkovic T, Stevanovic I (2012) Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis. J Neurol Sci 318:106\u2013111","journal-title":"J Neurol Sci"},{"key":"1691_CR64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fimmu.2013.00173","volume":"4","author":"C Patel","year":"2013","unstructured":"Patel C, Rojas M, Narayanan SP, Zhang W, Xu Z, Lemtalsi T et al (2013) Arginase as a mediator of diabetic retinopathy. Front Immunol 4:173","journal-title":"Front Immunol"},{"key":"1691_CR65","doi-asserted-by":"publisher","first-page":"H651","DOI":"10.1152\/ajpheart.00755.2012","volume":"305","author":"S Elms","year":"2013","unstructured":"Elms S, Chen F, Wang Y, Qian J, Askari B, Yu Y, Pandey D, Iddings J et al (2013) Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and enos. Am J Physiol Heart Circ Physiol 305:H651\u2013H666","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01691-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:21:17Z","timestamp":1593904877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01691-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01691-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}